(Q42586753)

3 November 2017

Postantibiotic effect of ceftaroline against gram-positive organisms (English)

1 reference

3 November 2017

gram-positive bacteria

0 references

author name string

G A Pankuch

series ordinal

1

1 reference

3 November 2017

P C Appelbaum

series ordinal

2

1 reference

3 November 2017

language of work or name

English

0 references

publication date

1 October 2009

1 reference

Antimicrobial Agents and Chemotherapy

3 November 2017

1 reference

3 November 2017

53

1 reference

3 November 2017

10

1 reference

3 November 2017

4537-4539

1 reference

In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae

3 November 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764186

In vitro profiling of ceftaroline against a collection of recent bacterial clinical isolates from across the United States

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764186

Ceftaroline fosamil, a cephalosporin derivative for the potential treatment of MRSA infection.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764186

Phase 2 study of ceftaroline versus standard therapy in treatment of complicated skin and skin structure infections

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764186

Postantibiotic effect of ceftobiprole against 12 Gram-positive organisms

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764186

Pharmacodynamics of a new cephalosporin, PPI-0903 (TAK-599), active against methicillin-resistant Staphylococcus aureus in murine thigh and lung infection models: identification of an in vivo pharmacokinetic-pharmacodynamic target

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764186

In vitro pharmacodynamic studies of L-749,345 in comparison with imipenem and ceftriaxone against gram-positive and gram-negative bacteria

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764186

The post-antibiotic sub-MIC effect in vitro and in vivo

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764186

Post-antibiotic effects in experimental infection models: relationship to in-vitro phenomena and to treatment of infections in man.

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764186

Antistaphylococcal activity of the novel cephalosporin CB-181963 (CAB-175).

28 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2764186

Kinetics of antimicrobial activity

16 August 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19770288

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.00785-09

1 reference

3 November 2017

1 reference

3 November 2017

PubMed publication ID

19770288

1 reference